Mercado Global de Glicosidases – Tendências da Indústria e Previsão para 2029

Análise e dimensão do mercado

Nos últimos anos, várias organizações iniciaram pesquisas académicas para criar novas ferramentas de glicómica e glicobiologia. Os procedimentos de caracterização de proteínas estão a avançar como resultado dos avanços na investigação química e bioquímica, como a cromatografia líquida de alta eficiência (HPLC) e a espectrometria de massa (MS). Estas técnicas produzem resultados rápidos e altamente sensíveis.

A Data Bridge Market Research analisa que o mercado das glicosidases deverá atingir o valor de 139,93 milhões de dólares até ao ano de 2029, com um CAGR de 11,3% no período de previsão. O mercado das glicosidases está a alcançar um crescimento significativo devido ao aumento da investigação e desenvolvimento em glicómica.

Definição de mercado

As glicosidases são enzimas que auxiliam na formação de ligações em açúcares complexos, bem como na degradação de biomassa como a celulose, hemicelulose e amido. São amplamente utilizados em diagnósticos, descoberta e desenvolvimento de fármacos, oncologia, imunologia e outras áreas.

Dinâmica do mercado das glicosidases

Motoristas

• Aumento da investigação e desenvolvimento, bem como elevada adoção de tecnologia

O aumento do investimento na investigação glicómica , o aumento dos gastos e a adoção de tecnologia avançada associada à instrumentação glicómica são alguns dos fatores que irão impulsionar o mercado das glicosidases durante o período de previsão de 2022-2029. Por outro lado, o aumento da aplicação dos países em desenvolvimento e dos mercados emergentes, bem como a necessidade de identificação de biomarcadores e a crescente utilização de medicamentos personalizados, criarão novas oportunidades para o crescimento do mercado das glicosidases durante o período de previsão.

• O aumento do custo das operações e o aumento da investigação académica

Várias organizações iniciaram pesquisas académicas para criar novas ferramentas de glicómica e glicobiologia. Os procedimentos de caracterização de proteínas estão a avançar como resultado dos avanços na investigação química e bioquímica, como a cromatografia líquida de alta eficiência (HPLC) e a espectrometria de massa (MS). Estas técnicas produzem resultados rápidos e altamente sensíveis. Espera-se também que um aumento da procura de medicamentos para tratar uma variedade de doenças crónicas graves alimente o crescimento do mercado da glicómica/glicobiologia.

Oportunidades

Por outro lado, o aumento da aplicação dos países em desenvolvimento e dos mercados emergentes, bem como a necessidade de identificação de biomarcadores e a crescente utilização de medicamentos personalizados, criarão novas oportunidades para o crescimento do mercado das glicosidases durante o período de previsão.

Restrições/Desafios

Strict rules and regulatory framework, as well as time-consuming processes and a high degree of consolidation, act as a restraint factor for the growth of the glycosidases market during the forecast period.

This glycosidases market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycosidases market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Glycosidases Market

Hydroxychloroquine, a commonly used drug, has seen a dramatic increase in demand for the treatment of COVID-19. Because many developed countries are running low on these drugs, the high demand has created enormous opportunities for manufacturers of COVID-19 management drugs. The pharmaceutical and biotechnology industries are expected to grow significantly in the future due to the demand for COVID-19 vaccines and treatment drugs. COVID 19 is expected to have a significant impact on the glycosidases market as a result of these factors.

Recent Development

• Agilent Technologies (US) introduced the InfinityLab LC/MSD iQ System in June 2019.
• Thermo Fisher Scientific (US) introduced the UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer in June 2018.

Global Glycosidases Market Scope

The glycosidases market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Enzymes
• Instruments
• Kits
• Reagents

Based on product, glycosidases market is segmented into enzymes, instruments, kits, reagents. Enzymes have been further sub-segmented into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases and other glycomics enzymes. Instruments have been further segmented into antibody arrays, HPLC, lectin arrays, MALDI-TOF, mass spectrometers and other. Kits have been further segmented into glycan labeling kits, glycan purification kits, glycan release kits and other kits. Reagents have been further segmented into glycoproteins, monosaccharides, oligosaccharides and other reagents.

Application

• Diagnostics
• Drug Discovery And Development
• Oncology
• Immunology 
• Other Applications

Based on applications, glycosidases market is segmented into diagnostics, drug discovery and development, oncology, immunology and other applications.

End User

• Academic Research Institutes
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations

Glycosidases market has also been segmented on the basis of end-user into academic research institutes, pharmaceutical and biotechnology companies and contract research organizations.

Glycosidases Market Regional Analysis/Insights

The glycosidases market is analysed and market size insights and trends are provided by country, product, application and end-user as referenced above.

The countries covered in the glycosidases market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The global market is expected to be dominated by North America, followed by Europe. The largest share of North America is primarily due to rising glycomics research investments, rising RandD investments in pharmaceutical companies for drug discovery, and the presence of all key players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The glycosidases market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glycosidases market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the glycosidases market. The data is available for historic period 2010-2020.

Competitive Landscape and Glycosidases Market Share Analysis

O panorama competitivo do mercado das glicosidases fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados fornecidos acima estão apenas relacionados com o foco das empresas relacionado com o mercado das glicosidases.

Alguns dos principais players que operam no mercado das glicosidases são a Agilent Technologies, Inc., New England Biolabs (UK) Ltd., Thermo Fisher Scientific Inc., Merck KGaA,, Takara Bio Inc., Waters Corporation, Geno Technology Inc., EUA ., Tecnologia DH. Dev. Pte. Ltd., Sumitomo Bakelite Co., Ltd., PerkinElmer Inc., Cambridge Isotope Laboratories, Inc., FUJIFILM Wako Pure Chemical Corporation, S-BIO, Vaupell Holdings Inc.; RandD Systems, Inc., Bruker, Danaher., Shimadzu Analytical (Índia) Unip. Ltd., RayBiotech, Inc., entre outros.

SKU-51887